APA (7th ed.) Citation

Smallwood, K., Tanis, J., Grant, I. A., Blackwood, L., Killick, D. R., Amores‐Fuster, I., . . . Finotello, R. (2019). Evaluation of a multi‐agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non‐Hodgkin high‐grade lymphomas: A single centre's experience. Veterinary & Comparative Oncology, 17(2), 165. https://doi.org/10.1111/vco.12457

Chicago Style (17th ed.) Citation

Smallwood, Katherine, et al. "Evaluation of a Multi‐agent Chemotherapy Protocol Combining Dexamethasone, Melphalan, Actinomycin D, and Cytarabine for the Treatment of Resistant Canine Non‐Hodgkin High‐grade Lymphomas: A Single Centre's Experience." Veterinary & Comparative Oncology 17, no. 2 (2019): 165. https://doi.org/10.1111/vco.12457.

MLA (9th ed.) Citation

Smallwood, Katherine, et al. "Evaluation of a Multi‐agent Chemotherapy Protocol Combining Dexamethasone, Melphalan, Actinomycin D, and Cytarabine for the Treatment of Resistant Canine Non‐Hodgkin High‐grade Lymphomas: A Single Centre's Experience." Veterinary & Comparative Oncology, vol. 17, no. 2, 2019, p. 165, https://doi.org/10.1111/vco.12457.